QuVa Pharma recalls

4 official recalls and safety alerts involving QuVa Pharma since 2022-10, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with QuVa Pharma or the relevant agency.

1. 2026-07-15
2. US
   Drugs & medicalClass II

   QuVa Pharma, Inc. recalls Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park One Dr, Suite 100,…

   Failed Impurities/Degradation Specifications

   FDA · DrugQuVa Pharma, Inc.Nationwide within the United StatesOfficial notice →
3. 2025-11-05
4. US
   Drugs & medicalClass II

   QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL…

   Presence of Particulate Matter

   FDA · DrugQuVa Pharma, Inc.U.S. NationwideOfficial notice →
5. 2025-04-02
6. US
   Drugs & medicalClass II

   QuVa Pharma, Inc. recalls fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection…

   Lack of Assurance of Sterility

   FDA · DrugQuVa Pharma, Inc.U.S. NationwideOfficial notice →
7. 2022-10-05
8. US
   Drugs & medicalClass III

   QuVa Pharma, Inc. recalls oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a Compounded Product for…

   Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).

   FDA · DrugQuVa Pharma, Inc.Nationwide in the USAOfficial notice →